Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure

Galectin-3 is a biomarker of heart disease. However, it remains unknown whether increase in galectin-3 levels is dependent on aetiology or disease-associated conditions and whether diseased heart releases galectin-3 into the circulation. We explored these questions in mouse models of heart disease a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, My-Nhan, Su, Yidan, Vizi, Donna, Fang, Lu, Ellims, Andris H., Zhao, Wei-Bo, Kiriazis, Helen, Gao, Xiao-Ming, Sadoshima, Junichi, Taylor, Andrew J., McMullen, Julie R., Dart, Anthony M., Kaye, David M., Du, Xiao-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973942/
https://www.ncbi.nlm.nih.gov/pubmed/29844319
http://dx.doi.org/10.1038/s41598-018-26115-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973942/
https://www.ncbi.nlm.nih.gov/pubmed/29844319
http://dx.doi.org/10.1038/s41598-018-26115-y

Ejemplares similares